Unique ID issued by UMIN | UMIN000039288 |
---|---|
Receipt number | R000044810 |
Scientific Title | Space-modulated proton therapy with polyglycolic acid spacer in pediatric tumor |
Date of disclosure of the study information | 2020/01/29 |
Last modified on | 2020/01/28 17:00:39 |
Space-modulated proton therapy with polyglycolic acid spacer in pediatric tumor
Space-modulated proton therapy with polyglycolic acid spacer
Space-modulated proton therapy with polyglycolic acid spacer in pediatric tumor
Space-modulated proton therapy with polyglycolic acid spacer
Japan |
Pediatric solid malignant tumo
Hematology and clinical oncology | Surgery in general | Pediatrics |
Radiology | Child |
Malignancy
NO
This trial evaluates the safety of the utilization of proton beam therapy with polyglycolic acid spacer replacement for pediatric solid tumor.
Safety
Frequencies of non-hematological toxicity greater than grade 3 by CTCAE criteria
1) Proton beam treatment completion rate
2) Spacer withdrawal rate
3) Dose volume distribution
4) Change of extension of treatment period
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
1
Treatment
Device,equipment | Maneuver |
Spacer replacement
1 | months-old | <= |
228 | months-old | >= |
Male and Female
1) Patients diagnosed with pediatric malignant solid tumor in abdominal or pelvic cavity.
2) The regions are limited and controlled.
3) Patients can be surgically replaced with PGA-spacer between the tumor and normal organ.
4) Patient age 30days or over 30 days and under 20 years.
5) Patients who can receive particle beam irradiation after PGA-spacer replacement.
6) Patients should obtain written consent if they are 16 years old or older. If they are under 16 years old, their proxies could do that for participation in this study.
1) Patients with active and refractory infection at their irradiated site
2) Patients who have digestive ulcer at the site of irradiation.
3) Patients with severe liver or kidney disfunction
4) Patients who are pregnant, breast-feeding, or cannot agree with contraception during this study.
5) Patients who have PAG allergy.
6) Patients who are judged inappropriate by the researcher in this study.
3
1st name | Michi |
Middle name | |
Last name | KAMEI |
Nagoya City University Graduate School of Medical Sciences
Department of Neonatology and Pediatrics
467-8601
1 Kawasumi, Mizuho-cyo, Mizuho-ku, Nagoya City, Aichi 467-8601, Japan
052-853-8246
mkamei@med.nagoya-cu.ac.jp
1st name | Michi |
Middle name | |
Last name | KAMEI |
Nagoya City University Graduate School of Medical Sciences
Department of Neonatology and Pediatrics
467-8601
1 Kawasumi, Mizuho-cyo, Mizuho-ku, Nagoya City, Aichi 467-8601, Japan
052-853-8246
mkamei@med.nagoya-cu.ac.jp
Nagoya City University Graduate School of Medical Sciences
Japan Agency for Medical Research and Development,
National Research and Development Corporation
Government offices of other countries
Japan
Clinical research manager center, Nagoya City University Hospital
1 Kawasumi, Mizuho-cho, Mizuho-ku Nagoya 467-8601, Japan
052-858-7215
clinical_research@med.nagoya-cu.ac.jp
NO
2020 | Year | 01 | Month | 29 | Day |
Unpublished
Open public recruiting
2019 | Year | 10 | Month | 15 | Day |
2019 | Year | 10 | Month | 24 | Day |
2019 | Year | 12 | Month | 01 | Day |
2021 | Year | 03 | Month | 31 | Day |
2020 | Year | 01 | Month | 28 | Day |
2020 | Year | 01 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044810
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |